Burney CO United Therapeutics Corp Transaction History

Burney CO

$2.54 Billion
Q3 2024

A detailed history of Burney CO transactions in United Therapeutics Corp stock. As of the latest transaction made, Burney CO holds 11,217 shares of UTHR stock, worth $4.05 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

11,217

Previous 15,966 29.74%

Holding current value

$4.05 Million

Previous $5.09 Million 20.96%

% of portfolio

0.16%

Previous 0.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$311.04 - $363.55 $1.48 Million - $1.73 Million	-4,749 Reduced 29.74%	11,217 $4.02 Million
Q2 2024 Jul 29, 2024	SELL	$228.26 - $319.04 $1.48 Million - $2.07 Million	-6,483 Reduced 28.88%	15,966 $5.09 Million
Q1 2024 May 22, 2024	BUY	$210.76 - $249.51 $2.57 Million - $3.05 Million	12,205 Added 119.14%	22,449 $5.16 Million
Q4 2023 Feb 12, 2024	BUY	$214.88 - $256.94 $60,166 - $71,943	280 Added 2.81%	10,244 $2.25 Million
Q3 2023 Nov 08, 2023	BUY	$211.82 - $248.24 $63,546 - $74,472	300 Added 3.1%	9,964 $2.25 Million
Q2 2023 Aug 09, 2023	SELL	$205.19 - $232.99 $35,292 - $40,074	-172 Reduced 1.75%	9,664 $2.13 Million
Q1 2023 May 10, 2023	SELL	$212.99 - $276.17 $39,190 - $50,815	-184 Reduced 1.84%	9,836 $2.2 Million
Q4 2022 Feb 06, 2023	SELL	$205.95 - $280.43 $8,855 - $12,058	-43 Reduced 0.43%	10,020 $2.79 Million
Q3 2022 Nov 15, 2022	SELL	$203.3 - $244.17 $105,919 - $127,212	-521 Reduced 4.92%	10,063 $2.11 Million
Q2 2022 Aug 12, 2022	SELL	$174.81 - $241.14 $3,496 - $4,822	-20 Reduced 0.19%	10,584 $2.49 Million
Q4 2021 Feb 11, 2022	SELL	$184.32 - $216.08 $56,954 - $66,768	-309 Reduced 2.83%	10,604 $2.29 Million
Q3 2021 Nov 12, 2021	SELL	$179.86 - $214.88 $46,763 - $55,868	-260 Reduced 2.33%	10,913 $2.01 Million
Q2 2021 Aug 06, 2021	SELL	$170.47 - $211.93 $8,353 - $10,384	-49 Reduced 0.44%	11,173 $2.01 Million
Q1 2021 May 13, 2021	SELL	$153.94 - $174.85 $57,573 - $65,393	-374 Reduced 3.23%	11,222 $1.88 Million
Q4 2020 Feb 11, 2021	SELL	$101.87 - $151.79 $49,610 - $73,921	-487 Reduced 4.03%	11,596 $1.76 Million
Q3 2020 Dec 14, 2020	SELL	$99.9 - $121.13 $18,781 - $22,772	-188 Reduced 1.53%	12,083 $1.22 Million
Q2 2020 Aug 13, 2020	SELL	$92.74 - $125.82 $43,031 - $58,380	-464 Reduced 3.64%	12,271 $1.49 Million
Q1 2020 May 13, 2020	SELL	$79.39 - $115.35 $18,418 - $26,761	-232 Reduced 1.79%	12,735 $1.21 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $40,329 - $49,100	-515 Reduced 3.82%	12,967 $1.14 Million
Q3 2019 Nov 12, 2019	SELL	$74.85 - $85.99 $3.52 Million - $4.05 Million	-47,085 Reduced 77.74%	13,482 $1.08 Million
Q2 2019 Aug 12, 2019	SELL	$76.06 - $120.81 $525,802 - $835,159	-6,913 Reduced 10.24%	60,567 $4.73 Million
Q1 2019 May 13, 2019	BUY	$107.15 - $126.84 $46,395 - $54,921	433 Added 0.65%	67,480 $7.92 Million
Q4 2018 Feb 12, 2019	SELL	$101.4 - $128.73 $596,434 - $757,189	-5,882 Reduced 8.07%	67,047 $7.3 Million
Q3 2018 Nov 13, 2018	SELL	$113.81 - $129.46 $1.27 Million - $1.45 Million	-11,186 Reduced 13.3%	72,929 $9.33 Million
Q2 2018 Aug 13, 2018	SELL	$101.14 - $118.31 $2.76 Million - $3.23 Million	-27,318 Reduced 24.52%	84,115 $9.52 Million
Q1 2018 May 08, 2018	SELL	$107.21 - $151.94 $917,074 - $1.3 Million	-8,554 Reduced 7.13%	111,433 $12.5 Million
Q4 2017 Feb 13, 2018	BUY	$118.58 - $151.28 $414,911 - $529,328	3,499 Added 3.0%	119,987 $17.8 Million
Q3 2017 Nov 13, 2017	SELL	$114.6 - $136.81 $382,534 - $456,671	-3,338 Reduced 2.79%	116,488 $13.8 Million
Q3 2017 Nov 09, 2017	BUY	$114.6 - $136.81 $13.7 Million - $16.4 Million	119,826	119,826 $15.7 Million

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.3M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account